Spaceflight Injectable Delivery System
Project Description
In the event of an emergency during spaceflight, it may be necessary for the crew to find extended safety in their Extra-Vehicular Activity (EVA) spacesuits. During this EVA contingency, NASA requires the capability to deliver liquid medications via intramuscular injection to ill or injured crewmembers. The delivery of liquid medication in a damaged vehicle unable to maintain a habitable environment poses unique challenges. Some of these challenges include the behavior of the fluid in a low-pressure and off-nominal-temperature environment, the formation of bubbles in microgravity, and the ability to physically use the medical delivery device at the desired anatomical location while the astronaut is suited. Under the auspices of NASA’s Human Research Program, the In-Suit Injection System project at the Glenn Research Center (GRC) aims to develop an injection device capable of delivering necessary medications during an EVA contingency.
More »
Anticipated Benefits
This technology development project aims to design a medical injection device for the harsh environment of space. This technology could translate to harsh Earth environments such as during underwater diving or during a hazardous materials/chemicals scenarios requiring the user to be in a containment suit.
More »
Primary U.S. Work Locations and Key Partners
| Organizations Performing Work | Role | Type | Location |
|---|---|---|---|
Johnson Space Center
(JSC)
|
Lead Organization | NASA Center | Houston, Texas |
Glenn Research Center
(GRC)
|
Supporting Organization | NASA Center | Cleveland, Ohio |
Primary U.S. Work Locations
-
Ohio
Suggest an Edit
This is a historic project that was completed before the creation of TechPort on October 1, 2012. Available data has been included. This record may contain less data than currently active projects.